TED (Trazodone在抑郁症中的有效性):特拉佐延长释放剂在对SSRI反应不满意的受试者中的有效性
Marcin Siwek1, Adrian Andrzej Chrobak2, Anna Julia Krupa1
1Uniwersytet Jagielloński Collegium Medicum, Katedra Psychiatrii, Zakład Zaburzeń Afektywnych.
Psychiatria polska
|March 14, 2024
概括
特拉佐XR的疗效与重度抑郁症 (MDD) 的新疗法相比,即使在选择性血清素再吸收抑制剂 (SSRI) 失败后,也具有可比的效果. 它改善了抑郁,焦虑,失眠和功能,并为之前服用SSRI的男性增加了性功能益处.
科学领域:
- 精神病学和临床神经科学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 大型抑郁症 (MDD) 影响着数百万人,选择性色素再吸收抑制剂 (SSRI) 是主要治疗方法.
- 很大一部分MDD患者 (约50%) 对SSRI反应不足,需要探索替代或二线疗法.
- 在MDD中SSRI无反应后,有效的二线治疗的证据仍然有限.
研究的目的:
- 评估Trazodone XR作为MDD的新生和二线治疗的疗效.
- 为了比较Trazodone XR在从SSRI转换的患者与最初接受Trazodone XR治疗的患者的疗效.
- 评估Trazodone XR对各种症状领域的影响,包括抑郁,焦虑,失眠,无情,心理社会功能和性功能.
主要方法:
- 分析了79名MDD患者的队列,分为de novoTrazodone XR治疗和从SSRI转换的患者.
- 标准化评估,包括蒙哥马利-阿斯伯格抑郁评分表和抑郁症状快速清单,用于测量抑郁症.
- 多个尺度评估了治疗效果,无情感,焦虑,失眠,心理社会功能和性功能在基线和长达12周的治疗效果.
主要成果:
- 治疗反应和缓解率在de novo和SSRI转换组之间是相似的.
- 特拉佐XR在两个患者队列中表现出可比的有效性.
- 在抑郁症,焦虑症,失眠症,无欲症和心理社会功能方面观察到显著的改善.
结论:
- 特拉佐XR是MDD患者对SSRI无反应的有效的二线治疗选择,其疗效与de novo治疗相当.
- 特拉佐XR在很大程度上改善了抑郁症状,焦虑,失眠,无情,并改善了MDD患者的心理社会功能.
- 值得注意的是,Trazodone XR改善了男性患者的性功能,这些患者之前曾经接受过SSRI治疗.
相关概念视频
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
384
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
384
01:23Antidepressant Drugs: MAOIs and Other Agents
228
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
228
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
01:25Antidepressant Drugs: Overview
477
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
477
01:19Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252